Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
Posted By Madilyn Moeller, Tuesday, December 17, 2024
Allergan Aesthetics, an AbbVie company, launched AMI Business Education, a new addition to the AMI Online learning platform available for free to all Allergan Aesthetics customers. This innovative offering empowers healthcare practitioners, their staff, and management with business education practices focused on Allergan Aesthetics products to enhance patient service and achieve operational excellence.
"Allergan Aesthetics designed AMI Business to meet providers where they are—supporting them with practical, business-focused education related to our products to complement their clinical expertise and help them grow their practices and deliver on patient needs," said Glen Curran, Senior Vice President, U.S. Allergan Aesthetics. "We are excited to provide these courses free of charge through AMI Online, giving all of our customers access to valuable resources that help them thrive in this dynamic industry."
With this latest launch, Allergan Aesthetics reinforces its investment in the AMI platform and its dedication to providing industry-leading education across both clinical and business disciplines. The AMI mission is to help practitioners develop their aesthetics expertise, elevate their clinical proficiency, and advance their practice.
The new AMI Business modules are aligned with Allergan Aesthetics' commitment to shaping, growing, and enhancing customers' businesses through robust education. Each course follows a "learning journey," addressing key business principles based on a clinic's tenure, to support the use of Allergan Aesthetics' products. By offering these tools, Allergan Aesthetics helps providers balance exceptional patient outcomes with efficient business operations.
The AMI Business Education curriculum is the first business program added to AMI Online and includes four courses that include seven newly launched e-trainings, all under 30 minutes.
Read more at AbbVie News Center >>